News

Investor's Business Daily on MSN18h
Dow Jones Futures: Netflix Earnings Crush Views After Weekly Market Losses. Palantir, MercadoLibre Setting Up.
The major indexes fell in the holiday-shortened week after hitting resistance. It's still a market correction. Netflix ...
Eli Lilly’s stock soars as successful trial of weight-loss pill is a game changer
If approved, the pill is expected to be far easier to administer than current injectables — and far easier to manufacture.
Eli Lilly Stock Soars on Weight-Loss News. Why It’s Bad for Novo Nordisk.
Eli Lilly said its new weight-loss pill had cleared a late-stage clinical trial, a promising sign as the company continues to ...
Yahoo Finance4d
Eli Lilly and Company (LLY): One of the High Growth Forever Dividend Stocks to Invest In
In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... according to S&P Dow Jones Indices. Dividend stocks have been performing well this year, even as broader ...
Eli Lilly CEO Ricks Warns Against Unintentionally Raising Prices as Weight-Loss Pill Nears Market Launch
Eli Lilly is getting closer to bringing a weight loss pill to market, but CEO David Ricks notes certain factors need to be considered to prevent prices from ballooning.
Dow Slides 500 Points As UnitedHealth Stock Heads To Worst Day In 17 Years
The UnitedHealth slide weighed heavily on the Dow, which fell 527 points, or 1.3%.
Morningstar17d
Hims & Hers Adds Eli Lilly's Zepbound in Expansion of Weight-Loss Offerings — 2nd Update
Hims & Hers Health said it is expanding its weight-loss offerings with the addition of Eli Lilly & Co.'s Zepbound and generic liraglutide. The telehealth-consultation platform on Tuesday said it ...
Most U.S. stocks rise, but UnitedHealth’s worst day in decades keeps Wall Street in check
Most U.S. stocks climbed Thursday, but the worst drop for UnitedHealth Group in a quarter of a century kept Wall Street in ...
Wall Street Journal16d
Hims & Hers Expands Weight Loss Offering, Adds Lilly’s Zepbound to Platform
Hims & Hers Health HIMS-6.01%decrease; red down pointing triangle said it is expanding its weight-loss offerings with the addition of Eli Lilly LLY 0.35%increase; green up pointing triangle & Co ...
Morningstar22d
CHMP Recommends Against Approval of Eli Lilly's Kisunla Alzheimer's Drug — Update
A key European regulatory committee has recommended against approval of Eli Lilly's Kisunla, saying the benefits of the Alzheimer's disease drug don't outweigh its risks. The European Medicines ...
24/7 Wall St. on MSN1d
Here’s Why Eli Lilly (NYSE: LLY). Fidelity National (NYSE: FIS) and Diamondback Energy (Nasdaq: FANG) Are Soaring Today
The Dow Jones Industrial Average is tumbling by another 440 points in midday trading today, as President Trump criticized ...